

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication-dependent nucleosome assembly (GO:0006335) | 8.83754021 |
| 2 | DNA replication-dependent nucleosome organization (GO:0034723) | 8.83754021 |
| 3 | * nucleosome assembly (GO:0006334) | 8.01633666 |
| 4 | chromatin assembly (GO:0031497) | 7.61717966 |
| 5 | * antimicrobial humoral response (GO:0019730) | 7.54336232 |
| 6 | nuclear pore complex assembly (GO:0051292) | 7.02399522 |
| 7 | * protein-DNA complex assembly (GO:0065004) | 6.78159919 |
| 8 | * nucleosome organization (GO:0034728) | 6.66794566 |
| 9 | regulation of histone H3-K9 methylation (GO:0051570) | 6.42048505 |
| 10 | axon ensheathment in central nervous system (GO:0032291) | 6.41371910 |
| 11 | central nervous system myelination (GO:0022010) | 6.41371910 |
| 12 | nuclear pore organization (GO:0006999) | 6.24270364 |
| 13 | * protein-DNA complex subunit organization (GO:0071824) | 5.81468313 |
| 14 | fatty acid elongation (GO:0030497) | 5.73594280 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.65056457 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 5.65056457 |
| 17 | pore complex assembly (GO:0046931) | 5.52105012 |
| 18 | chromatin assembly or disassembly (GO:0006333) | 5.48040337 |
| 19 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 5.26857550 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.19070682 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 5.19070682 |
| 22 | cholesterol biosynthetic process (GO:0006695) | 4.68242350 |
| 23 | DNA unwinding involved in DNA replication (GO:0006268) | 4.61495629 |
| 24 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.43913908 |
| 25 | DNA strand elongation (GO:0022616) | 4.27468047 |
| 26 | protein localization to chromosome, centromeric region (GO:0071459) | 4.17200989 |
| 27 | DNA replication initiation (GO:0006270) | 4.15628154 |
| 28 | nucleotide transmembrane transport (GO:1901679) | 4.10658823 |
| 29 | cysteine metabolic process (GO:0006534) | 4.08782233 |
| 30 | sterol biosynthetic process (GO:0016126) | 4.06821595 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 4.04484599 |
| 32 | creatine metabolic process (GO:0006600) | 4.01100667 |
| 33 | mitotic chromosome condensation (GO:0007076) | 4.00422835 |
| 34 | very long-chain fatty acid metabolic process (GO:0000038) | 3.93581102 |
| 35 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.84044047 |
| 36 | response to methylmercury (GO:0051597) | 3.83778807 |
| 37 | CENP-A containing nucleosome assembly (GO:0034080) | 3.82914325 |
| 38 | signal peptide processing (GO:0006465) | 3.82089765 |
| 39 | amyloid precursor protein catabolic process (GO:0042987) | 3.81647869 |
| 40 | mitotic sister chromatid segregation (GO:0000070) | 3.76781527 |
| 41 | regulation of megakaryocyte differentiation (GO:0045652) | 3.73769017 |
| 42 | ensheathment of neurons (GO:0007272) | 3.72004568 |
| 43 | axon ensheathment (GO:0008366) | 3.72004568 |
| 44 | myelin maintenance (GO:0043217) | 3.70106680 |
| 45 | sister chromatid segregation (GO:0000819) | 3.69599066 |
| 46 | myelination (GO:0042552) | 3.68748321 |
| 47 | aldehyde catabolic process (GO:0046185) | 3.66688215 |
| 48 | V(D)J recombination (GO:0033151) | 3.63460440 |
| 49 | viral mRNA export from host cell nucleus (GO:0046784) | 3.62353633 |
| 50 | heme transport (GO:0015886) | 3.59879226 |
| 51 | chromatin remodeling at centromere (GO:0031055) | 3.59114288 |
| 52 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.58690786 |
| 53 | * defense response to Gram-positive bacterium (GO:0050830) | 3.58128172 |
| 54 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.57030737 |
| 55 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.55077116 |
| 56 | amyloid precursor protein metabolic process (GO:0042982) | 3.54200994 |
| 57 | telomere maintenance via recombination (GO:0000722) | 3.50901838 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.48328671 |
| 59 | glyoxylate metabolic process (GO:0046487) | 3.47699206 |
| 60 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.46233681 |
| 61 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.46037656 |
| 62 | isoprenoid biosynthetic process (GO:0008299) | 3.45930183 |
| 63 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.44656689 |
| 64 | bile acid biosynthetic process (GO:0006699) | 3.41567530 |
| 65 | mature B cell differentiation involved in immune response (GO:0002313) | 3.36599431 |
| 66 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.34144583 |
| 67 | mitotic recombination (GO:0006312) | 3.32130800 |
| 68 | adhesion of symbiont to host cell (GO:0044650) | 3.30594643 |
| 69 | virion attachment to host cell (GO:0019062) | 3.30594643 |
| 70 | DNA duplex unwinding (GO:0032508) | 3.30246650 |
| 71 | alpha-linolenic acid metabolic process (GO:0036109) | 3.29013418 |
| 72 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.27980010 |
| 73 | tyrosine metabolic process (GO:0006570) | 3.27419827 |
| 74 | glutathione derivative biosynthetic process (GO:1901687) | 3.26827561 |
| 75 | glutathione derivative metabolic process (GO:1901685) | 3.26827561 |
| 76 | response to lead ion (GO:0010288) | 3.25578597 |
| 77 | regulation of sister chromatid cohesion (GO:0007063) | 3.24476062 |
| 78 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.23358549 |
| 79 | response to nitrosative stress (GO:0051409) | 3.20833593 |
| 80 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.19553015 |
| 81 | mitotic nuclear envelope disassembly (GO:0007077) | 3.19480296 |
| 82 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.18676868 |
| 83 | DNA synthesis involved in DNA repair (GO:0000731) | 3.18053665 |
| 84 | DNA geometric change (GO:0032392) | 3.17709354 |
| 85 | cellular glucuronidation (GO:0052695) | 3.14043231 |
| 86 | regulation of cholesterol metabolic process (GO:0090181) | 3.13846944 |
| 87 | sulfur amino acid catabolic process (GO:0000098) | 3.12818969 |
| 88 | regulation of lipoprotein metabolic process (GO:0050746) | 3.12605850 |
| 89 | cofactor catabolic process (GO:0051187) | 3.11320509 |
| 90 | uronic acid metabolic process (GO:0006063) | 3.11208332 |
| 91 | glucuronate metabolic process (GO:0019585) | 3.11208332 |
| 92 | embryonic process involved in female pregnancy (GO:0060136) | 3.08258173 |
| 93 | short-chain fatty acid metabolic process (GO:0046459) | 3.07415994 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.06723853 |
| 95 | peptidyl-lysine dimethylation (GO:0018027) | 3.03054349 |
| 96 | response to redox state (GO:0051775) | 3.01622948 |
| 97 | acyl-CoA biosynthetic process (GO:0071616) | 2.98257334 |
| 98 | thioester biosynthetic process (GO:0035384) | 2.98257334 |
| 99 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.97987255 |
| 100 | non-recombinational repair (GO:0000726) | 2.97987255 |
| 101 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.97559918 |
| 102 | negative regulation of DNA repair (GO:0045738) | 2.95472318 |
| 103 | aromatic amino acid family metabolic process (GO:0009072) | 2.94288873 |
| 104 | regulation of centrosome cycle (GO:0046605) | 2.93828038 |
| 105 | mitotic sister chromatid cohesion (GO:0007064) | 2.93714358 |
| 106 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.93531340 |
| 107 | membrane disassembly (GO:0030397) | 2.93026953 |
| 108 | nuclear envelope disassembly (GO:0051081) | 2.93026953 |
| 109 | * mucosal immune response (GO:0002385) | 2.92919291 |
| 110 | heme metabolic process (GO:0042168) | 2.91544558 |
| 111 | import into cell (GO:0098657) | 2.91450283 |
| 112 | cholesterol metabolic process (GO:0008203) | 2.89004566 |
| 113 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.88356928 |
| 114 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.88356928 |
| 115 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.88356928 |
| 116 | GPI anchor biosynthetic process (GO:0006506) | 2.87638539 |
| 117 | telomere maintenance (GO:0000723) | 2.87462628 |
| 118 | glutathione biosynthetic process (GO:0006750) | 2.87374655 |
| 119 | positive regulation of chromosome segregation (GO:0051984) | 2.87010594 |
| 120 | cellular ketone body metabolic process (GO:0046950) | 2.85667827 |
| 121 | telomere organization (GO:0032200) | 2.85400523 |
| 122 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.84630042 |
| 123 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.84193572 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.84193572 |
| 125 | replicative senescence (GO:0090399) | 2.84145606 |
| 126 | * organ or tissue specific immune response (GO:0002251) | 2.83719475 |
| 127 | nucleotide transport (GO:0006862) | 2.83667233 |
| 128 | thioester metabolic process (GO:0035383) | 2.83211869 |
| 129 | acyl-CoA metabolic process (GO:0006637) | 2.83211869 |
| 130 | * antibacterial humoral response (GO:0019731) | 2.82929448 |
| 131 | drug transmembrane transport (GO:0006855) | 2.82912725 |
| 132 | mature B cell differentiation (GO:0002335) | 2.82865276 |
| 133 | glutathione metabolic process (GO:0006749) | 2.81880391 |
| 134 | oligodendrocyte differentiation (GO:0048709) | 2.80923634 |
| 135 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.80276216 |
| 136 | proline biosynthetic process (GO:0006561) | 2.79998524 |
| 137 | plasma lipoprotein particle clearance (GO:0034381) | 2.79427001 |
| 138 | protein localization to kinetochore (GO:0034501) | 2.78980124 |
| 139 | B cell proliferation (GO:0042100) | 2.78381544 |
| 140 | regulation of chromosome segregation (GO:0051983) | 2.76762863 |
| 141 | positive regulation of histone methylation (GO:0031062) | 2.76529649 |
| 142 | B cell mediated immunity (GO:0019724) | 2.76189000 |
| 143 | response to lipoprotein particle (GO:0055094) | 2.75682258 |
| 144 | adhesion of symbiont to host (GO:0044406) | 2.75616639 |
| 145 | immunoglobulin mediated immune response (GO:0016064) | 2.75608533 |
| 146 | bile acid metabolic process (GO:0008206) | 2.75478456 |
| 147 | acetyl-CoA metabolic process (GO:0006084) | 2.75192594 |
| 148 | regulation of translational fidelity (GO:0006450) | 2.74660799 |
| 149 | heme biosynthetic process (GO:0006783) | 2.74538882 |
| 150 | ketone body metabolic process (GO:1902224) | 2.74331957 |
| 151 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.74294761 |
| 152 | fatty acid beta-oxidation (GO:0006635) | 2.73962885 |
| 153 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.73481992 |
| 154 | DNA replication-independent nucleosome organization (GO:0034724) | 2.73481992 |
| 155 | regulation of cholesterol esterification (GO:0010872) | 2.73419628 |
| 156 | opsonization (GO:0008228) | 2.73138885 |
| 157 | hemoglobin metabolic process (GO:0020027) | 2.72696953 |
| 158 | fatty acid catabolic process (GO:0009062) | 2.71738458 |
| 159 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.71566157 |
| 160 | regulation of centriole replication (GO:0046599) | 2.71503554 |
| 161 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.70840080 |
| 162 | histone exchange (GO:0043486) | 2.69551832 |
| 163 | coenzyme catabolic process (GO:0009109) | 2.69551281 |
| 164 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.69547413 |
| 165 | somatic cell DNA recombination (GO:0016444) | 2.69547413 |
| 166 | steroid biosynthetic process (GO:0006694) | 2.69234912 |
| 167 | regulation of gene silencing (GO:0060968) | 2.67838534 |
| 168 | fatty acid oxidation (GO:0019395) | 2.67433682 |
| 169 | sterol metabolic process (GO:0016125) | 2.66350879 |
| 170 | glycerophospholipid catabolic process (GO:0046475) | 2.66153250 |
| 171 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.65920354 |
| 172 | GPI anchor metabolic process (GO:0006505) | 2.65846432 |
| 173 | protein carboxylation (GO:0018214) | 2.65749155 |
| 174 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.65749155 |
| 175 | mitochondrial DNA metabolic process (GO:0032042) | 2.65700258 |
| 176 | lipid oxidation (GO:0034440) | 2.65089050 |
| 177 | photoreceptor cell differentiation (GO:0046530) | 2.64604124 |
| 178 | DNA conformation change (GO:0071103) | 2.63912311 |
| 179 | regulation of centrosome duplication (GO:0010824) | 2.62118926 |
| 180 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.56939972 |
| 181 | T cell lineage commitment (GO:0002360) | 2.56856317 |
| 182 | telomere maintenance via telomere lengthening (GO:0010833) | 2.56638434 |
| 183 | meiotic chromosome segregation (GO:0045132) | 2.56127232 |
| 184 | negative regulation of B cell apoptotic process (GO:0002903) | 2.54881457 |
| 185 | definitive hemopoiesis (GO:0060216) | 2.54752386 |
| 186 | kinetochore organization (GO:0051383) | 2.51216846 |
| 187 | T-helper 1 type immune response (GO:0042088) | 2.50934909 |
| 188 | histone phosphorylation (GO:0016572) | 2.49688062 |
| 189 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.48936437 |
| 190 | negative regulation of chromosome segregation (GO:0051985) | 2.48564198 |
| 191 | ATP-dependent chromatin remodeling (GO:0043044) | 2.48419700 |
| 192 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.47785516 |
| 193 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.47785516 |
| 194 | regulation of sister chromatid segregation (GO:0033045) | 2.47785516 |
| 195 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.47668284 |
| 196 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.47668284 |
| 197 | * innate immune response in mucosa (GO:0002227) | 10.5984556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.13977272 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.47582374 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.02105680 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.43397258 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.47605360 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.13344688 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.12276426 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.89933663 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.83130230 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.51856781 |
| 11 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.34860549 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.30635682 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.24637640 |
| 14 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.09853894 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.09505116 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 14.5161083 |
| 17 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.97445605 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.92833139 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.90451420 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81072657 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80643000 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.76736342 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.74482839 |
| 24 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.73606933 |
| 25 | GATA1_19941826_ChIP-Seq_K562_Human | 1.63962239 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63930689 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.54492683 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50268643 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48693395 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43820712 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41333942 |
| 32 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.39581358 |
| 33 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.34504005 |
| 34 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.34235354 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29892045 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27809560 |
| 37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.26424349 |
| 38 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26200724 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25109844 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24835757 |
| 41 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24042672 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22144590 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22144590 |
| 44 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21833003 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21637829 |
| 46 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16382167 |
| 47 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16273545 |
| 48 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.16064940 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.14957635 |
| 50 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13487243 |
| 51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13366784 |
| 52 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.13297198 |
| 53 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12064537 |
| 54 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.10325235 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10254058 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09876265 |
| 57 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09254678 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08871065 |
| 59 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08383694 |
| 60 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.08172394 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06783556 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05709774 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03889247 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02303239 |
| 65 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.02136877 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01970937 |
| 67 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.01310903 |
| 68 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99521803 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99379701 |
| 70 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98752573 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98383400 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96395103 |
| 73 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94032186 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93672759 |
| 75 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93349867 |
| 76 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92940017 |
| 77 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92621824 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 0.91992020 |
| 79 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91911879 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91154403 |
| 81 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91059047 |
| 82 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.90531594 |
| 83 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.90232294 |
| 84 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90097535 |
| 85 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89923368 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87349475 |
| 87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87262758 |
| 88 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.85748011 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84940450 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84524826 |
| 91 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84391544 |
| 92 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.84385090 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83991340 |
| 94 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.83426018 |
| 95 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.83371038 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81464029 |
| 97 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.81452071 |
| 98 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.80782505 |
| 99 | * MYB_26560356_Chip-Seq_TH1_Human | 0.80212488 |
| 100 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80063864 |
| 101 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.79489422 |
| 102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79321812 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78209271 |
| 104 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77908204 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77836576 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.77752476 |
| 107 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.76695163 |
| 108 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.76316905 |
| 109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76168371 |
| 110 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.75848947 |
| 111 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.75416039 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73803148 |
| 113 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.73712415 |
| 114 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.73496022 |
| 115 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.73257920 |
| 116 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.72319098 |
| 117 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.72133148 |
| 118 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.71986690 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71925990 |
| 120 | MYB_26560356_Chip-Seq_TH2_Human | 0.71203292 |
| 121 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.71168849 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.71044786 |
| 123 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70810265 |
| 124 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.70308374 |
| 125 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.68321881 |
| 126 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.68235917 |
| 127 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.68028710 |
| 128 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.67331570 |
| 129 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.66334166 |
| 130 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.66243591 |
| 131 | * MYC_18940864_ChIP-ChIP_HL60_Human | 0.65692470 |
| 132 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.64358476 |
| 133 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.63242906 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.62533320 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.62531348 |
| 136 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.61953318 |
| 137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.61546514 |
| 138 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.60996085 |
| 139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60650597 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.60549789 |
| 141 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60130957 |
| 142 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59969858 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.59679767 |
| 144 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.59435556 |
| 145 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.59374414 |
| 146 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.58994201 |
| 147 | UTX_26944678_Chip-Seq_JUKART_Human | 0.58957873 |
| 148 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58744884 |
| 149 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.58561183 |
| 150 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.58524094 |
| 151 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58493600 |
| 152 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.58382832 |
| 153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.58167404 |
| 154 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.58024098 |
| 155 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.57667286 |
| 156 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.57411833 |
| 157 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.57218406 |
| 158 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.57037372 |
| 159 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.56523999 |
| 160 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.55486436 |
| 161 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.55224650 |
| 162 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.55029279 |
| 163 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.54445610 |
| 164 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.53672416 |
| 165 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.53225026 |
| 166 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.52916396 |
| 167 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.52732305 |
| 168 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.52270231 |
| 169 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.52233103 |
| 170 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.51672752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.23852006 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 5.12291383 |
| 3 | MP0008057_abnormal_DNA_replication | 4.37814859 |
| 4 | MP0010094_abnormal_chromosome_stability | 4.30896774 |
| 5 | MP0005360_urolithiasis | 4.13147600 |
| 6 | MP0005365_abnormal_bile_salt | 3.52976160 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.52726251 |
| 8 | MP0000920_abnormal_myelination | 3.44599132 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.41597911 |
| 10 | MP0003656_abnormal_erythrocyte_physiolo | 3.37845293 |
| 11 | MP0003077_abnormal_cell_cycle | 3.36157235 |
| 12 | MP0003195_calcinosis | 3.23393283 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 3.12257210 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 3.09762728 |
| 15 | MP0003186_abnormal_redox_activity | 2.91592613 |
| 16 | MP0002009_preneoplasia | 2.91532677 |
| 17 | MP0003693_abnormal_embryo_hatching | 2.86725490 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.83806074 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.69814647 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.67473932 |
| 21 | MP0000685_abnormal_immune_system | 2.59708325 |
| 22 | MP0002396_abnormal_hematopoietic_system | 2.59625472 |
| 23 | MP0009840_abnormal_foam_cell | 2.58589261 |
| 24 | MP0004147_increased_porphyrin_level | 2.52518610 |
| 25 | MP0005083_abnormal_biliary_tract | 2.46565724 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.40963762 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.31152917 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 2.30998800 |
| 29 | MP0004043_abnormal_pH_regulation | 2.25771766 |
| 30 | MP0001835_abnormal_antigen_presentation | 2.25039379 |
| 31 | MP0008007_abnormal_cellular_replicative | 2.24431172 |
| 32 | MP0005058_abnormal_lysosome_morphology | 2.23791384 |
| 33 | MP0005332_abnormal_amino_acid | 2.21400245 |
| 34 | MP0003690_abnormal_glial_cell | 2.11558710 |
| 35 | MP0003950_abnormal_plasma_membrane | 2.10722084 |
| 36 | MP0010307_abnormal_tumor_latency | 2.07851843 |
| 37 | MP0005451_abnormal_body_composition | 2.07221123 |
| 38 | MP0003136_yellow_coat_color | 1.97140299 |
| 39 | MP0002398_abnormal_bone_marrow | 1.93676234 |
| 40 | MP0008058_abnormal_DNA_repair | 1.89915680 |
| 41 | MP0005408_hypopigmentation | 1.88293195 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.82551126 |
| 43 | MP0008932_abnormal_embryonic_tissue | 1.82388010 |
| 44 | MP0005671_abnormal_response_to | 1.77616198 |
| 45 | MP0002006_tumorigenesis | 1.76405477 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.75405250 |
| 47 | MP0001800_abnormal_humoral_immune | 1.74318243 |
| 48 | MP0000350_abnormal_cell_proliferation | 1.72330953 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.71244327 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.70154508 |
| 51 | MP0002722_abnormal_immune_system | 1.67249483 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.66152155 |
| 53 | MP0003252_abnormal_bile_duct | 1.65795457 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.64844353 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.60521378 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 1.57835275 |
| 57 | MP0003786_premature_aging | 1.56474768 |
| 58 | MP0000372_irregular_coat_pigmentation | 1.55107197 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.54065415 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.51842838 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.51589054 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.50321831 |
| 63 | MP0000490_abnormal_crypts_of | 1.49640577 |
| 64 | MP0003868_abnormal_feces_composition | 1.46058205 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37582230 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.37414592 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.37043068 |
| 68 | MP0002429_abnormal_blood_cell | 1.33415115 |
| 69 | MP0005171_absent_coat_pigmentation | 1.31721367 |
| 70 | MP0000462_abnormal_digestive_system | 1.31133306 |
| 71 | MP0000313_abnormal_cell_death | 1.29365594 |
| 72 | MP0000716_abnormal_immune_system | 1.26110019 |
| 73 | MP0002295_abnormal_pulmonary_circulatio | 1.25367746 |
| 74 | MP0004185_abnormal_adipocyte_glucose | 1.25318852 |
| 75 | MP0002086_abnormal_extraembryonic_tissu | 1.25228423 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 1.25109685 |
| 77 | MP0002452_abnormal_antigen_presenting | 1.23219418 |
| 78 | MP0004947_skin_inflammation | 1.22619275 |
| 79 | MP0002420_abnormal_adaptive_immunity | 1.21939466 |
| 80 | MP0002933_joint_inflammation | 1.21120433 |
| 81 | MP0004134_abnormal_chest_morphology | 1.20845595 |
| 82 | MP0003634_abnormal_glial_cell | 1.18936474 |
| 83 | MP0001730_embryonic_growth_arrest | 1.18037295 |
| 84 | MP0001764_abnormal_homeostasis | 1.17914654 |
| 85 | MP0000358_abnormal_cell_content/ | 1.17336378 |
| 86 | MP0001819_abnormal_immune_cell | 1.17136489 |
| 87 | MP0003011_delayed_dark_adaptation | 1.17111335 |
| 88 | MP0000609_abnormal_liver_physiology | 1.16864177 |
| 89 | MP0004381_abnormal_hair_follicle | 1.16669272 |
| 90 | MP0000569_abnormal_digit_pigmentation | 1.15607784 |
| 91 | MP0002723_abnormal_immune_serum | 1.15229951 |
| 92 | MP0001661_extended_life_span | 1.14624883 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 1.12234536 |
| 94 | MP0005387_immune_system_phenotype | 1.08973442 |
| 95 | MP0001790_abnormal_immune_system | 1.08973442 |
| 96 | MP0005076_abnormal_cell_differentiation | 1.08569014 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 1.08353300 |
| 98 | MP0003724_increased_susceptibility_to | 1.07305116 |
| 99 | MP0005220_abnormal_exocrine_pancreas | 1.04997805 |
| 100 | MP0001697_abnormal_embryo_size | 1.04532549 |
| 101 | MP0005380_embryogenesis_phenotype | 1.02826639 |
| 102 | MP0001672_abnormal_embryogenesis/_devel | 1.02826639 |
| 103 | MP0004885_abnormal_endolymph | 1.02629700 |
| 104 | MP0002080_prenatal_lethality | 1.01579093 |
| 105 | MP0003984_embryonic_growth_retardation | 1.01161097 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 0.97630574 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.97449162 |
| 108 | MP0002088_abnormal_embryonic_growth/wei | 0.97166366 |
| 109 | MP0001542_abnormal_bone_strength | 0.96937738 |
| 110 | MP0010155_abnormal_intestine_physiology | 0.96601764 |
| 111 | MP0009697_abnormal_copulation | 0.96310526 |
| 112 | MP0000604_amyloidosis | 0.95953653 |
| 113 | MP0003303_peritoneal_inflammation | 0.95157597 |
| 114 | MP0002090_abnormal_vision | 0.93772415 |
| 115 | MP0005310_abnormal_salivary_gland | 0.92850838 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.92842456 |
| 117 | MP0003718_maternal_effect | 0.89828854 |
| 118 | MP0001485_abnormal_pinna_reflex | 0.89363675 |
| 119 | MP0005397_hematopoietic_system_phenotyp | 0.89349393 |
| 120 | MP0001545_abnormal_hematopoietic_system | 0.89349393 |
| 121 | MP0003329_amyloid_beta_deposits | 0.88305842 |
| 122 | MP0006036_abnormal_mitochondrial_physio | 0.87947561 |
| 123 | MP0002229_neurodegeneration | 0.87462594 |
| 124 | MP0001727_abnormal_embryo_implantation | 0.87017704 |
| 125 | MP0006082_CNS_inflammation | 0.86060117 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.85823068 |
| 127 | MP0002877_abnormal_melanocyte_morpholog | 0.85635569 |
| 128 | MP0009763_increased_sensitivity_to | 0.85403866 |
| 129 | MP0001915_intracranial_hemorrhage | 0.83965790 |
| 130 | MP0005621_abnormal_cell_physiology | 0.82497174 |
| 131 | MP0003566_abnormal_cell_adhesion | 0.82228757 |
| 132 | MP0001905_abnormal_dopamine_level | 0.82038100 |
| 133 | MP0005384_cellular_phenotype | 0.81481733 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.77939228 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.77328901 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.77304344 |
| 137 | MP0008469_abnormal_protein_level | 0.76139811 |
| 138 | MP0010678_abnormal_skin_adnexa | 0.76089436 |
| 139 | MP0003075_altered_response_to | 0.75521835 |
| 140 | MP0005551_abnormal_eye_electrophysiolog | 0.75501575 |
| 141 | MP0002084_abnormal_developmental_patter | 0.74778493 |
| 142 | MP0008260_abnormal_autophagy | 0.73641299 |
| 143 | MP0001533_abnormal_skeleton_physiology | 0.73189452 |
| 144 | MP0006072_abnormal_retinal_apoptosis | 0.72506423 |
| 145 | MP0009384_cardiac_valve_regurgitation | 0.71920362 |
| 146 | MP0001851_eye_inflammation | 0.71400088 |
| 147 | MP0006054_spinal_hemorrhage | 0.70762364 |
| 148 | MP0005381_digestive/alimentary_phenotyp | 0.70640600 |
| 149 | MP0005164_abnormal_response_to | 0.70430738 |
| 150 | MP0005501_abnormal_skin_physiology | 0.69416193 |
| 151 | MP0001879_abnormal_lymphatic_vessel | 0.69044014 |
| 152 | MP0001191_abnormal_skin_condition | 0.68615007 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.68594865 |
| 154 | MP0005623_abnormal_meninges_morphology | 0.67999479 |
| 155 | MP0009764_decreased_sensitivity_to | 0.67546125 |
| 156 | MP0002419_abnormal_innate_immunity | 0.67122053 |
| 157 | MP0001216_abnormal_epidermal_layer | 0.66956967 |
| 158 | MP0009931_abnormal_skin_appearance | 0.66749505 |
| 159 | MP0002148_abnormal_hypersensitivity_rea | 0.66301571 |
| 160 | MP0008004_abnormal_stomach_pH | 0.65945492 |
| 161 | MP0009278_abnormal_bone_marrow | 0.65689508 |
| 162 | MP0001944_abnormal_pancreas_morphology | 0.65037833 |
| 163 | MP0001986_abnormal_taste_sensitivity | 0.64779636 |
| 164 | MP0001958_emphysema | 0.63434284 |
| 165 | MP0000230_abnormal_systemic_arterial | 0.63345676 |
| 166 | MP0009333_abnormal_splenocyte_physiolog | 0.63334419 |
| 167 | MP0002405_respiratory_system_inflammati | 0.62660306 |
| 168 | MP0002078_abnormal_glucose_homeostasis | 0.62455386 |
| 169 | MP0005025_abnormal_response_to | 0.61370678 |
| 170 | MP0005410_abnormal_fertilization | 0.61130006 |
| 171 | MP0004142_abnormal_muscle_tone | 0.61062306 |
| 172 | MP0005187_abnormal_penis_morphology | 0.60906973 |
| 173 | MP0002095_abnormal_skin_pigmentation | 0.60853073 |
| 174 | MP0005379_endocrine/exocrine_gland_phen | 0.60758239 |
| 175 | MP0005253_abnormal_eye_physiology | 0.59917988 |
| 176 | MP0002693_abnormal_pancreas_physiology | 0.59735123 |
| 177 | MP0000762_abnormal_tongue_morphology | 0.59468510 |
| 178 | MP0005376_homeostasis/metabolism_phenot | 0.59267120 |
| 179 | MP0005647_abnormal_sex_gland | 0.58934380 |
| 180 | MP0003795_abnormal_bone_structure | 0.58880851 |
| 181 | MP0009642_abnormal_blood_homeostasis | 0.57549861 |
| 182 | MP0002136_abnormal_kidney_physiology | 0.57545834 |
| 183 | MP0002896_abnormal_bone_mineralization | 0.57411309 |
| 184 | MP0001756_abnormal_urination | 0.56740278 |
| 185 | MP0000598_abnormal_liver_morphology | 0.56734376 |
| 186 | MP0000467_abnormal_esophagus_morphology | 0.55384480 |
| 187 | MP0000647_abnormal_sebaceous_gland | 0.55151948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 6.33583419 |
| 2 | IgA deficiency (HP:0002720) | 6.06135374 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.25082111 |
| 4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.70296247 |
| 5 | Colitis (HP:0002583) | 4.60641295 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.60562896 |
| 7 | Chromsome breakage (HP:0040012) | 4.32192356 |
| 8 | Gastrointestinal stroma tumor (HP:0100723) | 3.72664367 |
| 9 | Xanthomatosis (HP:0000991) | 3.59336355 |
| 10 | B lymphocytopenia (HP:0010976) | 3.52533872 |
| 11 | Cellulitis (HP:0100658) | 3.47312931 |
| 12 | Autoimmune hemolytic anemia (HP:0001890) | 3.33970915 |
| 13 | Thyroiditis (HP:0100646) | 3.24262365 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.22936686 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 3.22523169 |
| 16 | Parakeratosis (HP:0001036) | 3.19391119 |
| 17 | Abnormal platelet volume (HP:0011876) | 3.18594247 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.18375806 |
| 19 | Increased mean platelet volume (HP:0011877) | 3.16806295 |
| 20 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.12572889 |
| 21 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.12572889 |
| 22 | Abnormality of B cell number (HP:0010975) | 3.11543697 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.00806671 |
| 24 | Abnormality of chromosome stability (HP:0003220) | 2.97268383 |
| 25 | Deep venous thrombosis (HP:0002625) | 2.94417733 |
| 26 | Inflammation of the large intestine (HP:0002037) | 2.92433356 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 2.91637997 |
| 28 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.90774572 |
| 29 | Hyperlipoproteinemia (HP:0010980) | 2.89121708 |
| 30 | Abnormal tarsal ossification (HP:0008369) | 2.85512340 |
| 31 | Recurrent bronchitis (HP:0002837) | 2.85168608 |
| 32 | Recurrent sinusitis (HP:0011108) | 2.85085130 |
| 33 | Hyperbilirubinemia (HP:0002904) | 2.84469915 |
| 34 | Fat malabsorption (HP:0002630) | 2.84328976 |
| 35 | Petechiae (HP:0000967) | 2.82496069 |
| 36 | Squamous cell carcinoma (HP:0002860) | 2.79597267 |
| 37 | Acanthocytosis (HP:0001927) | 2.75510443 |
| 38 | Agammaglobulinemia (HP:0004432) | 2.75492086 |
| 39 | Hypoglycemic seizures (HP:0002173) | 2.73910929 |
| 40 | Recurrent viral infections (HP:0004429) | 2.71614614 |
| 41 | Lymphopenia (HP:0001888) | 2.70900514 |
| 42 | Abnormality of the preputium (HP:0100587) | 2.70690277 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 2.70674903 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.68708046 |
| 45 | Embryonal renal neoplasm (HP:0011794) | 2.66649886 |
| 46 | Spastic paraparesis (HP:0002313) | 2.66595787 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.63560624 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.63333622 |
| 49 | Lipid accumulation in hepatocytes (HP:0006561) | 2.62734389 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.62723107 |
| 51 | Medulloblastoma (HP:0002885) | 2.60576403 |
| 52 | Lymphoma (HP:0002665) | 2.60176091 |
| 53 | Steatorrhea (HP:0002570) | 2.59433633 |
| 54 | Axonal loss (HP:0003447) | 2.57838035 |
| 55 | Chronic diarrhea (HP:0002028) | 2.56393599 |
| 56 | Acute encephalopathy (HP:0006846) | 2.54878504 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 2.53822647 |
| 58 | Glycosuria (HP:0003076) | 2.53822647 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.53264501 |
| 60 | Hepatic necrosis (HP:0002605) | 2.50596317 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.50488082 |
| 62 | Myelodysplasia (HP:0002863) | 2.49631351 |
| 63 | Increased hepatocellular lipid droplets (HP:0006565) | 2.49335795 |
| 64 | Acute lymphatic leukemia (HP:0006721) | 2.48925426 |
| 65 | Erythema (HP:0010783) | 2.48361627 |
| 66 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.47100030 |
| 67 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.46387585 |
| 68 | Abnormality of the fingertips (HP:0001211) | 2.44984742 |
| 69 | Cerebral edema (HP:0002181) | 2.44303728 |
| 70 | Viral hepatitis (HP:0006562) | 2.43984660 |
| 71 | Poikilocytosis (HP:0004447) | 2.43892625 |
| 72 | Dry hair (HP:0011359) | 2.43493353 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.43396843 |
| 74 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.42754985 |
| 75 | Abnormality of methionine metabolism (HP:0010901) | 2.40258941 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.39840520 |
| 77 | Sensory axonal neuropathy (HP:0003390) | 2.39676368 |
| 78 | Stridor (HP:0010307) | 2.39103721 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.36088729 |
| 80 | Osteomyelitis (HP:0002754) | 2.35425851 |
| 81 | Prostate neoplasm (HP:0100787) | 2.33703780 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.32544087 |
| 83 | Hypobetalipoproteinemia (HP:0003563) | 2.32025466 |
| 84 | Symptomatic seizures (HP:0011145) | 2.31999960 |
| 85 | Hepatocellular necrosis (HP:0001404) | 2.31214404 |
| 86 | Epiphyseal dysplasia (HP:0002656) | 2.30532206 |
| 87 | Conjugated hyperbilirubinemia (HP:0002908) | 2.30330001 |
| 88 | Ketosis (HP:0001946) | 2.29829120 |
| 89 | Abnormality of renal resorption (HP:0011038) | 2.29596026 |
| 90 | Basal cell carcinoma (HP:0002671) | 2.29088327 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 2.27957912 |
| 92 | Subacute progressive viral hepatitis (HP:0006572) | 2.27917759 |
| 93 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.27742489 |
| 94 | IgG deficiency (HP:0004315) | 2.27728644 |
| 95 | Mitochondrial inheritance (HP:0001427) | 2.27480018 |
| 96 | Acute necrotizing encephalopathy (HP:0006965) | 2.26503161 |
| 97 | Meningitis (HP:0001287) | 2.26231405 |
| 98 | Abnormality of the ileum (HP:0001549) | 2.25568514 |
| 99 | Menorrhagia (HP:0000132) | 2.25023090 |
| 100 | Dyschromatopsia (HP:0007641) | 2.24276957 |
| 101 | Hypokalemic alkalosis (HP:0001949) | 2.23453869 |
| 102 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.22216502 |
| 103 | Joint hemorrhage (HP:0005261) | 2.22015935 |
| 104 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20186326 |
| 105 | Protuberant abdomen (HP:0001538) | 2.19981639 |
| 106 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.19235824 |
| 107 | Abnormality of glycine metabolism (HP:0010895) | 2.19235824 |
| 108 | Epistaxis (HP:0000421) | 2.18864365 |
| 109 | Increased muscle lipid content (HP:0009058) | 2.17786984 |
| 110 | Orthostatic hypotension (HP:0001278) | 2.16897934 |
| 111 | Clubbing of toes (HP:0100760) | 2.15114121 |
| 112 | Amyloidosis (HP:0011034) | 2.15071938 |
| 113 | Prominent nose (HP:0000448) | 2.14939396 |
| 114 | Abnormality of T cell physiology (HP:0011840) | 2.14926123 |
| 115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.13819045 |
| 116 | Abnormality of glycolysis (HP:0004366) | 2.13784008 |
| 117 | Increased serum pyruvate (HP:0003542) | 2.13784008 |
| 118 | Papillary thyroid carcinoma (HP:0002895) | 2.13581343 |
| 119 | Abnormality of the carotid arteries (HP:0005344) | 2.13434041 |
| 120 | Combined immunodeficiency (HP:0005387) | 2.13327033 |
| 121 | Vascular calcification (HP:0004934) | 2.12564189 |
| 122 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12192525 |
| 123 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.11995601 |
| 124 | Leiomyosarcoma (HP:0100243) | 2.11959210 |
| 125 | Uterine leiomyosarcoma (HP:0002891) | 2.11959210 |
| 126 | Leukodystrophy (HP:0002415) | 2.11459346 |
| 127 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07858385 |
| 128 | Deep philtrum (HP:0002002) | 2.06758185 |
| 129 | Onycholysis (HP:0001806) | 2.06615785 |
| 130 | Hepatosplenomegaly (HP:0001433) | 2.06003471 |
| 131 | Hepatitis (HP:0012115) | 2.05705583 |
| 132 | Paraparesis (HP:0002385) | 2.04552194 |
| 133 | Abnormal platelet function (HP:0011869) | 2.03404061 |
| 134 | Impaired platelet aggregation (HP:0003540) | 2.03404061 |
| 135 | Spontaneous hematomas (HP:0007420) | 2.03341671 |
| 136 | Severe combined immunodeficiency (HP:0004430) | 2.03253175 |
| 137 | Abnormal foot bone ossification (HP:0010675) | 2.02946591 |
| 138 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00375335 |
| 139 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00115831 |
| 140 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99777673 |
| 141 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98279715 |
| 142 | Purpura (HP:0000979) | 1.98056242 |
| 143 | Hyperphosphaturia (HP:0003109) | 1.97952294 |
| 144 | Beaking of vertebral bodies (HP:0004568) | 1.97862525 |
| 145 | Interstitial pulmonary disease (HP:0006530) | 1.97703009 |
| 146 | Leukopenia (HP:0001882) | 1.97297929 |
| 147 | Patchy hypopigmentation of hair (HP:0011365) | 1.97079423 |
| 148 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.96482428 |
| 149 | Ketoacidosis (HP:0001993) | 1.95925509 |
| 150 | Dicarboxylic aciduria (HP:0003215) | 1.95915637 |
| 151 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95915637 |
| 152 | Cerebral inclusion bodies (HP:0100314) | 1.95832559 |
| 153 | Ileus (HP:0002595) | 1.94248904 |
| 154 | Hypolipoproteinemia (HP:0010981) | 1.94133023 |
| 155 | Meckel diverticulum (HP:0002245) | 1.93810398 |
| 156 | Irregular epiphyses (HP:0010582) | 1.93161551 |
| 157 | Small intestinal stenosis (HP:0012848) | 1.92486552 |
| 158 | Duodenal stenosis (HP:0100867) | 1.92486552 |
| 159 | Cholelithiasis (HP:0001081) | 1.92369930 |
| 160 | Short 4th metacarpal (HP:0010044) | 1.91940149 |
| 161 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.91940149 |
| 162 | Septate vagina (HP:0001153) | 1.90397030 |
| 163 | Cardiovascular calcification (HP:0011915) | 1.90206887 |
| 164 | Progressive macrocephaly (HP:0004481) | 1.89985085 |
| 165 | Ridged nail (HP:0001807) | 1.89928761 |
| 166 | Episodic fever (HP:0001954) | 1.89913829 |
| 167 | Small epiphyses (HP:0010585) | 1.89613620 |
| 168 | Hypochromic microcytic anemia (HP:0004840) | 1.89251030 |
| 169 | Bladder carcinoma (HP:0002862) | 1.88727855 |
| 170 | Bladder neoplasm (HP:0009725) | 1.88727855 |
| 171 | Abnormal hemoglobin (HP:0011902) | 1.88500946 |
| 172 | Hypomagnesemia (HP:0002917) | 1.88066581 |
| 173 | Alkalosis (HP:0001948) | 1.87742067 |
| 174 | Cupped ribs (HP:0000887) | 1.86995499 |
| 175 | Metabolic alkalosis (HP:0200114) | 1.84820425 |
| 176 | Hyperglycinuria (HP:0003108) | 1.84566196 |
| 177 | Epidermoid cyst (HP:0200040) | 1.84025747 |
| 178 | Abnormality of magnesium homeostasis (HP:0004921) | 1.83900358 |
| 179 | Oral leukoplakia (HP:0002745) | 1.83637390 |
| 180 | Rickets (HP:0002748) | 1.83595003 |
| 181 | Micronodular cirrhosis (HP:0001413) | 1.83394557 |
| 182 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.82983620 |
| 183 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.82480722 |
| 184 | Recurrent bacterial skin infections (HP:0005406) | 1.81957693 |
| 185 | Birth length less than 3rd percentile (HP:0003561) | 1.81532178 |
| 186 | Progressive external ophthalmoplegia (HP:0000590) | 1.81049429 |
| 187 | Conjunctival telangiectasia (HP:0000524) | 1.80770504 |
| 188 | Dysautonomia (HP:0002459) | 1.79798338 |
| 189 | Hypergonadotropic hypogonadism (HP:0000815) | 1.77946322 |
| 190 | Cafe-au-lait spot (HP:0000957) | 1.77629973 |
| 191 | Gastrointestinal carcinoma (HP:0002672) | 1.73312766 |
| 192 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.73312766 |
| 193 | Spastic diplegia (HP:0001264) | 1.71045029 |
| 194 | Acute myeloid leukemia (HP:0004808) | 1.70713156 |
| 195 | Entropion (HP:0000621) | 1.70703019 |
| 196 | Ankyloglossia (HP:0010296) | 1.70576399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 5.62129143 |
| 2 | ZAK | 4.23244246 |
| 3 | STK39 | 3.90251775 |
| 4 | PBK | 3.52909665 |
| 5 | OXSR1 | 2.97966388 |
| 6 | EPHB1 | 2.73534425 |
| 7 | MET | 2.50851419 |
| 8 | MAPK15 | 2.46530326 |
| 9 | RPS6KA5 | 2.41954626 |
| 10 | VRK1 | 2.23178413 |
| 11 | WNK4 | 2.22530584 |
| 12 | PKN1 | 2.22488817 |
| 13 | MST4 | 2.19712899 |
| 14 | BCKDK | 2.09579318 |
| 15 | MAP2K2 | 2.00497353 |
| 16 | MAPKAPK5 | 1.94429995 |
| 17 | BCR | 1.93272861 |
| 18 | AURKA | 1.87305909 |
| 19 | BUB1 | 1.83097768 |
| 20 | STK4 | 1.80329322 |
| 21 | CDC7 | 1.72101940 |
| 22 | BMPR1B | 1.68742693 |
| 23 | STK16 | 1.65635789 |
| 24 | SMG1 | 1.59445223 |
| 25 | TNIK | 1.52740117 |
| 26 | CSNK1G3 | 1.38648289 |
| 27 | MST1R | 1.36695818 |
| 28 | CHEK2 | 1.32487092 |
| 29 | CSNK1A1L | 1.31343720 |
| 30 | AURKB | 1.29339120 |
| 31 | TAF1 | 1.16519540 |
| 32 | CSNK1G1 | 1.15580403 |
| 33 | EEF2K | 1.15208202 |
| 34 | BRSK2 | 1.12346564 |
| 35 | TAOK3 | 1.10712833 |
| 36 | CDK19 | 1.08788515 |
| 37 | INSRR | 1.07239324 |
| 38 | DAPK3 | 1.00424577 |
| 39 | ERBB4 | 1.00004200 |
| 40 | WNK1 | 0.98995576 |
| 41 | MAP3K10 | 0.97781611 |
| 42 | TRPM7 | 0.96008035 |
| 43 | LIMK1 | 0.95847565 |
| 44 | PIM2 | 0.91057200 |
| 45 | DYRK3 | 0.89827746 |
| 46 | EPHA2 | 0.88157059 |
| 47 | NEK6 | 0.87003364 |
| 48 | BMPR2 | 0.86828705 |
| 49 | FGFR2 | 0.85174940 |
| 50 | PRKCQ | 0.85145785 |
| 51 | PIM1 | 0.84884750 |
| 52 | PIK3CA | 0.84440761 |
| 53 | CDK9 | 0.83430299 |
| 54 | TTK | 0.81579158 |
| 55 | CAMK2D | 0.80885610 |
| 56 | NEK1 | 0.79660813 |
| 57 | RPS6KB2 | 0.79365089 |
| 58 | PIK3CG | 0.79066677 |
| 59 | CSNK1G2 | 0.77863170 |
| 60 | BRAF | 0.77066195 |
| 61 | CDK12 | 0.76902211 |
| 62 | ABL2 | 0.73426453 |
| 63 | BLK | 0.73347899 |
| 64 | SCYL2 | 0.72055209 |
| 65 | SYK | 0.71817003 |
| 66 | MAP3K14 | 0.71625350 |
| 67 | MUSK | 0.71011651 |
| 68 | CCNB1 | 0.70859083 |
| 69 | SGK494 | 0.70673032 |
| 70 | SGK223 | 0.70673032 |
| 71 | NME2 | 0.68924817 |
| 72 | PRKG2 | 0.68878276 |
| 73 | CAMK2B | 0.68473733 |
| 74 | ERN1 | 0.68414273 |
| 75 | MAP3K2 | 0.68291034 |
| 76 | TESK2 | 0.65768611 |
| 77 | IKBKB | 0.65292699 |
| 78 | ARAF | 0.63664326 |
| 79 | SRPK1 | 0.63414589 |
| 80 | DYRK1B | 0.61353956 |
| 81 | CAMK2G | 0.60913991 |
| 82 | CDK8 | 0.60632590 |
| 83 | WNK3 | 0.59942188 |
| 84 | ATR | 0.58791298 |
| 85 | TRIB3 | 0.58677865 |
| 86 | GSK3A | 0.58047268 |
| 87 | NTRK1 | 0.57252992 |
| 88 | ROCK2 | 0.55520047 |
| 89 | IRAK4 | 0.51860761 |
| 90 | AKT2 | 0.49076039 |
| 91 | IRAK1 | 0.48735332 |
| 92 | MAP2K3 | 0.47842353 |
| 93 | CDK7 | 0.47312963 |
| 94 | NLK | 0.46716998 |
| 95 | PRKAA1 | 0.46593609 |
| 96 | DYRK2 | 0.46567534 |
| 97 | HIPK2 | 0.45855440 |
| 98 | MAPK11 | 0.45851544 |
| 99 | MELK | 0.45625589 |
| 100 | IKBKE | 0.44715058 |
| 101 | PLK4 | 0.44388663 |
| 102 | EPHA3 | 0.43362869 |
| 103 | FLT3 | 0.42909046 |
| 104 | EIF2AK3 | 0.42688717 |
| 105 | PLK1 | 0.41370646 |
| 106 | WEE1 | 0.41262123 |
| 107 | RAF1 | 0.40643084 |
| 108 | MAP2K1 | 0.39604752 |
| 109 | MAP2K7 | 0.39322696 |
| 110 | FGR | 0.39032426 |
| 111 | TEC | 0.38987458 |
| 112 | JAK2 | 0.38892765 |
| 113 | CDK6 | 0.38738865 |
| 114 | MAP3K8 | 0.38319173 |
| 115 | CLK1 | 0.37808568 |
| 116 | PAK3 | 0.37236840 |
| 117 | GRK1 | 0.37149514 |
| 118 | LYN | 0.36026348 |
| 119 | ICK | 0.35211656 |
| 120 | NEK9 | 0.35174910 |
| 121 | PRKD1 | 0.34827678 |
| 122 | PRPF4B | 0.34755806 |
| 123 | CHEK1 | 0.34432943 |
| 124 | ROCK1 | 0.33866324 |
| 125 | MAPK7 | 0.33256335 |
| 126 | TBK1 | 0.32918551 |
| 127 | MAP3K3 | 0.32766569 |
| 128 | CAMKK2 | 0.31413394 |
| 129 | PAK1 | 0.31364491 |
| 130 | PKN2 | 0.31126737 |
| 131 | CDK4 | 0.30929981 |
| 132 | MAPK4 | 0.30887331 |
| 133 | MAP3K4 | 0.30804559 |
| 134 | RIPK4 | 0.30144648 |
| 135 | ITK | 0.29940206 |
| 136 | FRK | 0.28416410 |
| 137 | PRKCD | 0.28337994 |
| 138 | EIF2AK1 | 0.28140847 |
| 139 | ATM | 0.27743399 |
| 140 | CSNK1D | 0.26474064 |
| 141 | HCK | 0.26066914 |
| 142 | BTK | 0.25185324 |
| 143 | NUAK1 | 0.25163935 |
| 144 | PLK3 | 0.24799264 |
| 145 | PDPK1 | 0.24665784 |
| 146 | RET | 0.24522120 |
| 147 | IRAK3 | 0.24254634 |
| 148 | ERBB3 | 0.23331979 |
| 149 | PRKCE | 0.23310400 |
| 150 | CSF1R | 0.23079118 |
| 151 | MAP4K1 | 0.22629741 |
| 152 | NEK2 | 0.22269157 |
| 153 | STK3 | 0.21587868 |
| 154 | CDK2 | 0.21041694 |
| 155 | STK24 | 0.20618824 |
| 156 | ILK | 0.18915498 |
| 157 | BRSK1 | 0.17669508 |
| 158 | TTN | 0.15977024 |
| 159 | CAMK4 | 0.14809850 |
| 160 | EIF2AK2 | 0.14478539 |
| 161 | CDK1 | 0.12436852 |
| 162 | TSSK6 | 0.11022569 |
| 163 | MAP2K4 | 0.10614419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 4.69791651 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.32115284 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.18648810 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.77484904 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.71897419 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.64536908 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.56083030 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.43982595 |
| 9 | * Alcoholism_Homo sapiens_hsa05034 | 2.42159260 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.37289818 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32983104 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.25497614 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19626964 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05667664 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03276052 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01066242 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.98764165 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.94032798 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.89759548 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.86796525 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86331944 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85195179 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81788098 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.71425527 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.61444400 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58410443 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58239828 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56690759 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56348629 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.53232662 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51615166 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45521336 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41063006 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40895951 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.38766760 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.34626824 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.33828691 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33751806 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.31743930 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30275175 |
| 41 | Cell cycle_Homo sapiens_hsa04110 | 1.29995070 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28641575 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.28088388 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21843172 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15013256 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.13405555 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11182368 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10288038 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08622660 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.06442484 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.05561508 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04889950 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04791512 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04497467 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.04377871 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03465333 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 1.02129098 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01639773 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.01160850 |
| 60 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.99984180 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 0.99817902 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98698022 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97500995 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97031308 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.96097604 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94643714 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91826822 |
| 68 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90805050 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89411455 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89309893 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87159412 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84926975 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83664753 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83292413 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81631452 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80768212 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80632833 |
| 78 | Base excision repair_Homo sapiens_hsa03410 | 0.80380252 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79351213 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79345540 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76930934 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72062760 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.71267662 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70760096 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70554266 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69253354 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.67456340 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66049303 |
| 89 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66021178 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62829098 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.61671882 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60851662 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59311728 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58971617 |
| 95 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58896037 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58309556 |
| 97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.55387142 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.55298386 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55031084 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51800586 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51018925 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50089642 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50059091 |
| 104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49304192 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49163439 |
| 106 | RNA transport_Homo sapiens_hsa03013 | 0.48598706 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48111501 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47441202 |
| 109 | Glioma_Homo sapiens_hsa05214 | 0.45412696 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45380198 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44312247 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.44097489 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42541699 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.40215081 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.39657545 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.39436455 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39188902 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38516407 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.37622094 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37274623 |
| 121 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36061763 |
| 122 | Spliceosome_Homo sapiens_hsa03040 | 0.35657280 |
| 123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35495193 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34982548 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34569644 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33878634 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.33343814 |
| 128 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33094923 |
| 129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31963226 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30520694 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30335696 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29932896 |
| 133 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29743379 |
| 134 | Prostate cancer_Homo sapiens_hsa05215 | 0.29487841 |
| 135 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29437007 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29326486 |
| 137 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28069064 |
| 138 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27745156 |
| 139 | Purine metabolism_Homo sapiens_hsa00230 | 0.27413858 |
| 140 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26261796 |
| 141 | Carbon metabolism_Homo sapiens_hsa01200 | 0.26249788 |
| 142 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26225253 |
| 143 | Phagosome_Homo sapiens_hsa04145 | 0.26096038 |
| 144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24092927 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.23270286 |
| 146 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23145633 |
| 147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21287533 |
| 148 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.20471747 |
| 149 | Ribosome_Homo sapiens_hsa03010 | 0.20411123 |
| 150 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.20186844 |
| 151 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.19368841 |
| 152 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18407856 |
| 153 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.18091306 |
| 154 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.17978466 |
| 155 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.17717475 |
| 156 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17271992 |
| 157 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17097795 |
| 158 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.15391907 |
| 159 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13865209 |
| 160 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13536061 |
| 161 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.13405630 |
| 162 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.13174209 |
| 163 | Shigellosis_Homo sapiens_hsa05131 | 0.13098211 |
| 164 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12686212 |
| 165 | RNA polymerase_Homo sapiens_hsa03020 | 0.12543563 |
| 166 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11645112 |
| 167 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.11408861 |
| 168 | Tuberculosis_Homo sapiens_hsa05152 | 0.10915027 |
| 169 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.10325197 |
| 170 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10220477 |
| 171 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.10142743 |
| 172 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09851644 |
| 173 | Prion diseases_Homo sapiens_hsa05020 | 0.09698733 |
| 174 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.08462010 |
| 175 | RNA degradation_Homo sapiens_hsa03018 | 0.07940408 |
| 176 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.07292137 |
| 177 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.06824032 |
| 178 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.06312165 |
| 179 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.05804498 |
| 180 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.05758212 |
| 181 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.05646944 |
| 182 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.03582688 |

